CD19 and Alzheimer disease: The results showed that percentages of SP-expressing CD4+, CD8+, CD16+, and CD19+ cells, but not CD123+HLA-DR− and CD14+ cells, were increased in the blood of AD patients compared with HC blood (Fig. 2a, b).